Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

75,570 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
hECA: The cell-centric assembly of a cell atlas.
Chen S, Luo Y, Gao H, Li F, Chen Y, Li J, You R, Hao M, Bian H, Xi X, Li W, Li W, Ye M, Meng Q, Zou Z, Li C, Li H, Zhang Y, Cui Y, Wei L, Chen F, Wang X, Lv H, Hua K, Jiang R, Zhang X. Chen S, et al. Among authors: li f, li c, li j, li w, li h. iScience. 2022 Apr 28;25(5):104318. doi: 10.1016/j.isci.2022.104318. eCollection 2022 May 20. iScience. 2022. PMID: 35602947 Free PMC article.
Correction: Influence of the carbazole moiety in self-assembling molecules as selective contacts in perovskite solar cells: interfacial charge transfer kinetics and solar-to-energy efficiency effects.
González DA, Puerto Galvis CE, Li W, Méndez M, Aktas E, Martínez-Ferrero E, Palomares E. González DA, et al. Among authors: li w. Nanoscale Adv. 2024 May 3;6(10):2728. doi: 10.1039/d4na90051k. eCollection 2024 May 14. Nanoscale Adv. 2024. PMID: 38752142 Free PMC article.
Business culture impairs facial trustworthiness judgments.
Zhang H, Liu Y, Li W, Nie M, Xin Z. Zhang H, et al. Among authors: li w. Front Psychol. 2024 May 1;15:1356305. doi: 10.3389/fpsyg.2024.1356305. eCollection 2024. Front Psychol. 2024. PMID: 38751767 Free PMC article.
Efficacy and safety of margetuximab plus chemotherapy vs. trastuzumab plus chemotherapy in Chinese patients with pretreated HER2-positive advanced metastatic breast cancer: results from a randomized, open-label, multicenter, phase II bridging study.
Zhang Q, Ouyang Q, Li W, Chiu J, Yan M, Lu YS, Sun S, Li H, Du Y, Wang X, Sun T, Yin Y, Wang H, Ye F, Shen K, Wang J, Pan Y, Wang S, Yang J, Wu X, Dai MS, Cheng J, Teng Y, Su F, Wu X, He J, Fu P, Yang L, Xin Y, Wang X, Jiang Z. Zhang Q, et al. Among authors: li w. Transl Breast Cancer Res. 2022 Oct 31;3:31. doi: 10.21037/tbcr-22-35. eCollection 2022. Transl Breast Cancer Res. 2022. PMID: 38751523 Free PMC article.
Primary results of ELAINA: a randomized, multicenter, open-label, phase III study of the efficacy and safety of trastuzumab emtansine vs. lapatinib plus capecitabine in Chinese patients with HER2-positive locally advanced or metastatic breast cancer who have received prior trastuzumab-based therapy.
Wang X, Li W, Yin Y, Tong Z, Zhang Q, Zheng H, Shao Z, Li H, Yang J, Feng J, Wu F, Lamour F, Restuccia E, Jiang Z. Wang X, et al. Among authors: li w. Transl Breast Cancer Res. 2023 Jan 31;4:3. doi: 10.21037/tbcr-23-2. eCollection 2023. Transl Breast Cancer Res. 2023. PMID: 38751488 Free PMC article.
75,570 results
You have reached the last available page of results. Please see the User Guide for more information.